FindTrial
Sign In

Evaluation of curative effect and surgical risk of surgical approaches for the treatment of Moyamoya disease and Moyamoya syndrome by Pseudo-continuous Arterial Spin Labeled Perfusion Magnetic Resonance Imaging

Evaluation of curative effect and surgical risk of surgical approaches for the treatment of Moyamoya disease and Moyamoya syndrome by Pseudo-continuous Arterial Spin Labeled Perfusion Magnetic Resonance Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110853
Enrollment
Unknown
Registered
2025-10-21
Start date
2023-05-23
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya disease

Interventions

Direct bypass:NA
Indirect bypass:NA

Sponsors

Sanbo Brain Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with MMD or MMS who were clinically diagnosed and underwent direct / indirect bypass surgery in our hospital. 2.Patients underwent ASL MRI examination during perioperative period. 3.Volunteers participated in the imaging follow-up study. 4.The subjects voluntarily participated in the study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.MMD or MMS patients who have not been operated in our hospital. 2.No ASL MRI examination in perioperative period. 3.The subjects did not participate in the imaging follow-up study. 4.Patients aged > 80 and < 3 years old. 5.The subjects did not sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Brain Flow;—

Secondary

MeasureTime frame
Brain area;—

Countries

China

Contacts

Public ContactLiu Fangjun

Sanbo Brain Hospital Capital Medical University

liufangjun@mail.ccmu.edu.cn+86 10 6285 6737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026